4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-25-097006
Options or other derivatives
- Chief Medical Officer acquired 65,110 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kerr Douglas · Chief Medical Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-07-16 | Grant or award : show line 1 in the form Stock option (right to buy) | +65,110 | 65,110 | D |
Loading xslF345X05/ownership.xml…